Crossmark

Administration of losartan preserves cardiomyocyte size and prevents myocardial dysfunction in tail-suspended mice by inhibiting p47phox phosphorylation, NADPH oxidase activation and MuRF1 expression

Crossref DOI link: https://doi.org/10.1186/s12967-019-2021-1

Published Online: 2019-08-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Liwen

Yuan, Wenyi

Qu, Lina

Li, Huili

Zhang, Lulu

Fan, Guo-Chang

Peng, Tianqing https://orcid.org/0000-0002-5199-9016
Funding

Funding for this research was provided by:

the State Key Laboratory of Space Medicine Fundamentals and Application, Chinese Astronaut Research and Training Center (SMFA15K02)
License Information

Text and Data Mining valid from 2019-08-22

Version of Record valid from 2019-08-22
More Information

Article History

Received: 5 May 2019

Accepted: 13 August 2019

First Online: 22 August 2019

Ethics approval and consent to participate

: Not applicable.

: All co-authors have approved the submission of the manuscript for publication in its present form.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below